Skip to main navigation Skip to search Skip to main content

A prospective, randomized evaluation of a novel everolimus-eluting coronary stent: the PLATINUM (a Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System [PROMUS Element] for the Treatment of Up to Two de Novo Coronary Artery Lesions) trial

Gregg W Stone, Paul S Teirstein, Ian T Meredith, Bruno Farah, Christophe L Dubois, Robert L Feldman, Joseph Dens, Nobuhisa Hagiwara, Dominic J Allocco, Keith D Dawkins, PLATINUM Trial Investigators, Henning Kelbæk

    209 Citations (Scopus)

    Abstract

    We sought to evaluate the clinical outcomes with a novel platinum chromium everolimus-eluting stent (PtCr-EES) compared with a predicate cobalt chromium everolimus-eluting stent (CoCr-EES) in patients undergoing percutaneous coronary intervention (PCI).
    Original languageEnglish
    JournalAmerican College of Cardiology. Journal
    Volume57
    Issue number16
    Pages (from-to)1700-8
    Number of pages9
    ISSN0735-1097
    DOIs
    Publication statusPublished - 2011

    Keywords

    • Aged
    • Coronary Artery Disease
    • Drug-Eluting Stents
    • Female
    • Follow-Up Studies
    • Humans
    • Male
    • Middle Aged
    • Prospective Studies
    • Single-Blind Method
    • Sirolimus
    • Treatment Outcome

    Fingerprint

    Dive into the research topics of 'A prospective, randomized evaluation of a novel everolimus-eluting coronary stent: the PLATINUM (a Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System [PROMUS Element] for the Treatment of Up to Two de Novo Coronary Artery Lesions) trial'. Together they form a unique fingerprint.

    Cite this